Bioclinix Medical Diagnostics Centre has congratulated its Advisor on Molecular Diagnostics, Dr. Elekofehinti Olusola, for being named among the top two percent of researchers globally, a recognition that highlights his outstanding contributions to science, innovation, and biomedical research.
Olusola, an Associate Professor of Biochemistry, Federal University of Technology, Akure is widely respected for his pioneering work in bioinformatics, molecular biology, and biomedical drug design and development.
His research has advanced global understanding in the fields of computational biology, drug discovery, and molecular diagnostics.
The recognition, compiled from global citation metrics, places Dr. Olusola among a distinguished group of scholars whose research has had significant impact worldwide.
DON'T MISS
Speaking on the milestone, Dr. Isaac Olatunde, CEO of Bioclinix Medical Diagnostics Centre, described the recognition as both an inspiration and a validation of Bioclinix’s commitment to excellence in diagnostics.
“We are proud to have Dr. Olusola as part of the Bioclinix team. His expertise in bioinformatics and molecular diagnostics is invaluable to our vision of advancing healthcare delivery in Nigeria. This global recognition shows that our advisor is not just shaping science locally, but contributing meaningfully to the global body of knowledge.”
Dr. Olusola’s role at Bioclinix as Advisor on Molecular Diagnostics is to guide the Centre in developing cutting-edge diagnostic services, build research collaborations, and mentor the next generation of scientists.
With this recognition, Bioclinix believes that Nigeria’s diagnostic and biomedical research sector can continue to compete on the global stage, drawing strength from local expertise with international impact.
